Blowfish Tablet, Effervescent
NDC Package 75920-0464-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Blowfish (aspirin, caffeine) tablets is upon waking, fully dissolve 2 tablets in 16 oz. This formulation utilizes a tablet, effervescent delivery system. Marketed by Rally Labs Llc, this product is identified by NDC 75920-0464 and is authorized under FDA application M013.

Identification & Billing

NDC Package Code
75920-0464-2
Package Description
20 TABLET, EFFERVESCENT in 1 BAG
Product Code
11-Digit Billing Format
75920046402
RxNorm Crosswalk
  • RxCUI: 1537019 - aspirin 500 MG / caffeine 60 MG Effervescent Oral Tablet
  • RxCUI: 1537019 - ASA 500 MG / Caffeine 60 MG Effervescent Oral Tablet

Clinical Specifications

Proprietary Name
Blowfish
Non-Proprietary Name
Aspirin, Caffeine
Substance Name
Aspirin; Caffeine
Dosage Form
Tablet, Effervescent - A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Upon waking, fully dissolve 2 tablets in 16 oz. of water and drinkdo not exceed recommended dosageAdults and children 12 years and over(up to 60 years of age) 2 tablets every 6 hours, as needed, or as directed by a doctor. Do not exceed 8 tablets in 24 hoursAdults 60 years and over2 tablets every 6 hours, as needed, or as directed by a doctor. Do not exceed 4 tablets in 24 hoursChildren under 12 yearsDo not use

Regulatory & Marketing

Labeler Name
Rally Labs Llc
Product Type
Human Otc Drug
FDA Application #
M013
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-23-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (75920-0464). Click a package code to view its specific billing and regulatory data.

2 TABLET, EFFERVESCENT in 1 BOX
40 TABLET, EFFERVESCENT in 1 BAG
20 TABLET, EFFERVESCENT in 1 BOX
4 TABLET, EFFERVESCENT in 1 BOX
20 TABLET, EFFERVESCENT in 1 BOX
12 TABLET, EFFERVESCENT in 1 BOX

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75920-0464-2 identifies a specific commercial package of 20 tablet, effervescent in 1 bag of Blowfish, a human over the counter drug labeled by Rally Labs Llc. This tablet, effervescent is formulated for oral use and contains aspirin; caffeine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rally Labs Llc on July 23, 2011. The current certification is valid through December 31, 2026.

How is this Rally Labs Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75920046402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
75920-0464-2
11-Digit CMS (5-4-2)
75920-0464-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.